Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy

Clinical trial NCT07220811 · RECRUITING

Trial details

NCT number: NCT07220811
Sponsor: RAPT Therapeutics, Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Ig-E Mediated Food Allergy

Start date: 2025-10-22
Primary completion: 2027-04-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.